logo-loader
RNS
viewAmphion Innovations PLC

Settlement of loan facility

/**/ p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}link{ color: blue }visited{ color: #954F72 } .w{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.w{}p.bl{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal}span.bj{font-size:12.0pt}p.bm{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";border: none; font-weight: bold; line-height: normal; text-align: center}span.bh{font-variant:small-caps}p.bn{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";border: none; font-weight: bold; line-height: normal}p.bo{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify;line-height:normal}p.bc{margin:0cm;margin-bottom:.0001pt;text-align:justify;background:white}span.bd{font-size:11.0pt;font-family:"Calibri","sans-serif"} p.bp{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-div: italic; line-height: normal; text-align: justify}span.bb{color:black}p.ay{font-weight: bold; margin: 0cm; margin-bottom: .0001pt}span.az{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}table.bq{margin-left:5.65pt;border-collapse:collapse;border:none}tr.au{height:12.0pt}td.ax{width:216.05pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt}td.av{width:219.0pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt}p.br{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";border: none; line-height: normal; text-align: right}p.bs{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height:normal;border:none} p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";}tr.aq{height:24.0pt}td.as{width:317.9pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:24.0pt}td.ar{width:117.15pt;border:none;padding:4.0pt 4.0pt 4.0pt 4.0pt; height:24.0pt}td.ap{width:259.25pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt}td.ao{width:175.8pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt}td.an{width:216.05pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:24.0pt}td.am{width:219.0pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:24.0pt}span.al{color:#1A1A1A}td.ak{width:251.25pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt} td.aj{width:183.8pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt}td.ai{width:147.7pt;border:none;padding:4.0pt 4.0pt 4.0pt 4.0pt; height:12.0pt}td.ag{width:287.35pt;border:none; padding:4.0pt 4.0pt 4.0pt 4.0pt;height:12.0pt}span.ah{color: blue; text-decoration: underline}p.bt{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height:normal}td.ae{border:none}p.ab{margin:0cm;margin-bottom:.0001pt}span.ac{font-size: 11.0pt;font-family:"Calibri","sans-serif";color:black}p.bu{margin-right:0cm;margin-left:0cm;font-size:10.0pt;font-family:"Times","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify}span.bv{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold} span.bw{color:black}span.bx{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}span.by{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}span.x{font-size:11.0pt;font-family: "Calibri","sans-serif";color:black} /**/
RNS Number : 3062Q
Amphion Innovations PLC
18 October 2019
 

 

AMPHION INNOVATIONS PLC

 ("Amphion" or "the Company")

 

 

Settlement of Loan Facility

 

London and New York, 18 October 2019 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that further to the sale of Amphion's total holding of 15,972,523 shares in Polarean Imaging plc ("Polarean") which was announced on 11 October 2019 ("Sale"), the Lender of the Facility has subsequently confirmed to Amphion that the total net proceeds arising from the Sale were US $2.6 million. The Lender has also confirmed that in accordance with the terms of the Facility, substantially all of the net Sale proceeds were applied by the Lender to repayment of the Facility and following the Sale, the loan Facility has been settled and there are no outstanding obligations to the Lender. 

 

Amphion remains highly cash constrained. Further to the Company's announcement on 27 June 2019, the Company's shares remaining suspended from trading on AIM.  

 

Other than as defined above, capitalised terms are as set out in the Company's announcement dated 11 October 2019.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").

 

 

For further information please contact:

 

Amphion Innovations

Tel: +1 (212) 210 6224

Charlie Morgan




Panmure Gordon Limited (Nominated Adviser and Corporate Broker)

Tel: +44 (0)20 7886 2500

Emma Earl/ Freddy Crossley  (Corporate Finance)


Charles Leigh-Pemberton (Corporate Broking)




SP Angel Corporate Finance LLP (Joint Corporate Broker)

Tel: +44 (0) 20 3470 0470

David Hignell (Corporate Finance)


Vadim Alexandre (Corporate Broking)




Walbrook PR

Tel: +44 (0)20 7933 8780 or [email protected]

Anna Dunphy / Paul McManus




 

About Amphion Innovations plc

 

Amphion Innovations is a developer of medical, life science and technology businesses.

 

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in a few Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.

 

On the web: www.amphionplc.com 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCBRBDGSBBBGCR

Quick facts: Amphion Innovations PLC

Price: 0.15

Market: AIM
Market Cap: £314.96 k
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amphion Innovations hails favourable court ruling

Richard Morgan, chief executive of Amphion Innovations (LON:AMP), explains the ins and outs of the ruling it has received in a US federal court relating to its patented intellectual property. He tells Proactive Investors that the company has been striving to protect a software patent related...

on 04/14/2014